Pro Medicus Limited
PME
Pozycja w akcjach
#1600
Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a... Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a leading provider of medical imaging software and services. The company develops and delivers advanced solutions to hospitals, diagnostic imaging groups, and other healthcare organizations across Australia, North America, and Europe. Their core offerings include proprietary Radiology Information Systems (RIS), which streamline practice management and come with comprehensive support, training, installation, and professional services. Pro Medicus also operates Promedicus.net, an e-health platform, and supplies sophisticated imaging software designed to provide radiologists and clinicians with powerful visualization capabilities for 2D, 3D, and 4D medical images. This suite of tools is further enhanced by Picture Archiving and Communication System (PACS)/digital imaging software and integration products. Additionally, they offer mobile applications like Visage Ease Pro, which enables remote interpretation of diagnostic imaging studies stored on a Visage 7 server. Key product brands include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease.
Cena akcji
$129.30
Kapitalizacja rynkowa
$13.51B
Zmiana (1 dzień)
-0.17%
Zmiana (1 rok)
-30.83%
Kraj
AU
Handel Pro Medicus Limited (PME)
Kategoria
Healthcare
Przychody dla Pro Medicus Limited (PME)
Przychody w Jun 2026 TTM: $184.56M
Według najnowszych raportów finansowych Pro Medicus Limited, obecny przychód firmy (TTM) wynosi $184.56M. W roku 2024 firma osiągnęła przychód w wysokości $107.79M wzrost w porównaniu do przychodu z roku 2023, który wynosił $83.22M. Przychód to całkowita kwota dochodu generowana przez firmę ze sprzedaży towarów lub usług. W przeciwieństwie do zysku, nie są odliczane żadne koszty.
Historia przychodów firmy Pro Medicus Limited od 2000 do 2026
Przychody na koniec każdego roku
| Rok | Przychody | Zmień |
|---|---|---|
| 2026 (TTM) | $184.56M | 31.68% |
| 2025 | $140.16M | 30.03% |
| 2024 | $107.79M | 29.52% |
| 2023 | $83.22M | 29.09% |
| 2022 | $64.46M | 26.65% |
| 2021 | $50.90M | 29.82% |
| 2020 | $39.21M | 11.42% |
| 2019 | $35.19M | 32.27% |
| 2018 | $26.60M | 9.34% |
| 2017 | $24.33M | 18.68% |
| 2016 | $20.50M | 52.25% |
| 2015 | $13.47M | 0.06% |
| 2014 | $13.46M | 32.04% |
| 2013 | $10.19M | -11.85% |
| 2012 | $11.56M | -22.81% |
| 2011 | $14.98M | -7.87% |
| 2010 | $16.26M | 102.15% |
| 2009 | $8.04M | -8.44% |
| 2008 | $8.78M | -17.50% |
| 2007 | $10.65M | 26.89% |
| 2006 | $8.39M | 7.33% |
| 2005 | $7.82M | 42.49% |
| 2004 | $5.49M | -10.08% |
| 2003 | $6.10M | 6.64% |
| 2002 | $5.72M | 12.69% |
| 2001 | $5.08M | 0.00% |
| 2000 | 0.00 | 0.00% |
Przychody podobnych firm lub konkurentów
| Firma | Przychody | Różnica w przychodach | Kraj |
|---|---|---|---|
| $20.24B | 10,867.98% |
US
|
|
| $14.37B | 7,686.76% |
US
|
|
| $1.43B | 675.89% |
US
|
|
| $616.91M | 234.25% |
US
|
|
| - | - |
US
|
